Article
17 Dec 2025
Most Favored Nation Drug Pricing And Manufacturer Agreements
AUTHORS CONTENT
Article
17 Dec 2025
The Current Legal Landscape Of The 340B Drug Pricing Program
Article
17 Dec 2025
FDA's Support For Onshoring Drug Manufacturing And Increasing Oversight Of Foreign Facilities
Article
09 Dec 2025
FDA's Biosimilar Playbook: Merging Biosimilarity With Interchangeability
Article
06 Nov 2025
FDA Proposes To Remove Comparative Efficacy Studies To Accelerate Biosimilar Development
Article
18 Aug 2025
HHS Pilot Program To Evaluate 340B Drug Pricing Program Rebate Models